Evidence against a Human Cell-Specific Role for LRP6 in Anthrax Toxin Entry
Patricia L. Ryan, John A. T. Young · 2008
Read Evidence against a Human Cell-Specific Role for LRP6 in Anthrax Toxin Entry by Patricia L. Ryan, John A. T. Young (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001817.txt.
Introduction
Patricia L. Ryan and John A. T. Young tested a disputed claim about anthrax toxin entry in a 2008 PLOS ONE research article. The cellular protein LRP6 had been reported as important for efficient intoxication of a human prostate carcinoma cell line, M2182. Other studies, using cells from gene-knockout mice, found no role for LRP6 at all. The contradiction mattered for understanding how anthrax toxin enters cells.
Ryan and Young present evidence against a human cell-specific role for LRP6 in anthrax toxin entry. The full text gives their cell tests and toxin assays. Settling which host proteins the toxin truly needs focuses biodefense research on entry routes that are real.
Catalog record
| CREATOR | Patricia L. Ryan, John A. T. Young |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 22 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001817
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Evidence against a Human Cell-Specific Role for LRP6 in Anthrax Toxin Entry Authors: Patricia L. Ryan, John A. T. Young Published: 2008, PLOS ONE DOI: 10.1371/journal.pone.0001817 ABSTRACT The role of the cellular protein LRP6 in anthrax toxin entry is controversial. Previous studies showed that LRP6 was important for efficient intoxication of human M2182 prostate carcinoma cells but other studies performed with cells from gene-knockout mice demonstrated no role for either LRP6 or the related LRP5 protein in anthrax toxin entry. One possible explanation for this discrepancy is that LRP6 may be important for anthrax toxin entry into human, but not mouse, cells. To test this idea we have investigated the effect of knocking down LRP6 or LRP5 expression with siRNAs in human HeLa cells. We show here that efficient knockdown of either LRP6, LRP5, or both proteins has no influence on the kinetics of anthrax lethal toxin entry or MEK1 substrate cleavage in these cells. These data argue against a human-specific role for LRP6 in anthrax toxin entry and suggest instead that involvement of this protein may be restricted to certain cell types independently of their species of origin. INTRODUCTION Bacillus anthracis , the etiological agent of anthrax, secretes a tripartite toxin, which is one of two major virulence factors. Anthrax toxin is composed of the receptor binding moiety, protective antigen (PA), and two catalytic moieties: Lethal factor (LF), a zinc –dependent metalloprotease that cleaves MAP kinase kinases (MAPKKs), [1] – [3] and edema factor (EF), a calcium- and calmodulin-dependent adenylate cyclase that raises cAMP levels [4] . LF and EF combine with PA to form lethal toxin (LeTx) and edema toxin (EdTx), respectively. Both 83 kD and 63 kD forms of PA (PA 83 and PA 63 ) can bind to either of two cellular receptors, ANTXR1 (anthrax toxin receptor 1/tumor endothelial marker 8; ATR/TEM8) or ANTXR2 (anthrax toxin receptor 2/capillary morphogenesis factor 2;CMG2) [5] , [6] . Receptor-bound PA 83 is cleaved by cell-surface furin into the 63 kD form [7] . PA 63 forms a heptameric ring structure [PA 63(7) ], termed a prepore, at neutral pH [8] . EF and LF bind the prepore and the toxin/receptor complex is endocytosed primarily via clathrin-mediated endocytosis [9] and trafficked to an endocytic compartment where low-pH triggers PA 63(7) pore formation and translocation of EF and LF into the cytosol [10] – [12] . Currently there is a controversy about the role played in anthrax toxin entry by the low-density lipoprotein receptor-related protein LRP6, which interacts with both ANTXR1 and ANTXR2 [13] . Evidence in favor of a specific role was provided by Cohen and colleagues [13] . In that study, LRP6 was identified through a genome-wide antisense RNA screening approach to be important for intoxication of human M2182 prostate carcinoma cells by PA and FP59, a recombinant toxin comprised of the N-terminal portion of LF fused to Pseudomonas exotoxin A. Consistently, siRNA-mediated knockdown of LRP6 levels in these cells reduced their toxin sensitivity by several orders of magnitude, an effect that was partially overcome by expression of an siRNA-resistant form of LRP6. LRP6 deficiency in M2182 cells was also associated with reduced levels of PA binding and pore formation, and expression of a dominant-negative form of LRP6, lacking its cytoplasmic domain, rendered these cells resistant to intoxication. This group also showed that LRP6 could be co-precipitated with both ANTXR1 and ANTXR2. Furthermore, they showed that siRNA-mediated knockdown of LRP6 rendered RAW264.7 mouse macrophages resistant to intoxication by PA and LF, although this effect was much more modest (∼3-fold) than that seen with M2182 cells. LRP6-specific antibodies also protected RAW264.7 cells from intoxication. By contrast, Duesbury and colleagues found that LRP6 +/− and LRP5 −/− mice were just as susceptible to killing after LeTx injection as wild-type mice [14] . LRP5 is a protein that is highly related to LRP6 [15] . In addition, they showed that mouse embryo fibroblasts (MEFs) that were isolated from LRP6 −/− or LRP5 −/− mice were just as susceptible to intoxication by PA and FP59, and to MEK1 cleavage by LF and PA, as those isolated from wild-type mice [14] . They went on to show that there is no obvious receptor-specific role for LRP6 since knocking down this protein had no effect on the toxin sensitivity of PA receptor-deficient Chinese hamster ovary cells that were engineered to express either ANTXR1 or ANTXR2. Duesbury and colleagues put forward several possible explanations for the discrepant results. Since their data argue against an anthrax toxin receptor-specific role for LRP6, and there is no evidence for functional redundancy between LRP6 and LRP5 in toxin entry, they suggested that instead LRP6 might function in either a human-specific or cell type-specific manner. In this report we show that siRNA-mediated knockdown of LRP6 and/or LRP5 levels has no impact on the kinetics of anthrax toxin entry into human HeLa cells. These data argue against a human-specific role for either LRP6 or LRP5 in anthrax toxin entry and suggest that the requirement for LRP6 might be restricted to certain cell types. RESULTS AND DISCUSSION HeLa cells were chosen as a model human cell type because they have been used extensively for anthrax toxin entry studies and they are efficiently transfected with siRNAs [9] , [16] , [17] . To determine the efficiency of knocking down LRP6 or LRP5 expression, these cells were transfected with cognate siRNAs. These studies revealed an approximately 20-fold decrease in LRP5 and a 10-fold decrease in LRP6 mRNA transcripts in the transfected HeLa cells, relative to the levels observed with cells transfected with a negative control siRNA directed against luciferase ( Fig. 1A ). Consistently, siRNA transfection significantly reduced LRP5 and LRP6 proteins levels, as judged by immunoblotting ( Fig. 1B and 1C ). Importantly, LRP6 protein was reduced to undetectable levels in HeLa cells transfected with the corresponding siRNAs ( Fig. 1B and C ). Taken together these studies show that expression of LRP5 and LRP6 can be markedly reduced in siRNA-transfected HeLa cells. In addition, the level of siRNA-mediated knock-down of LRP5 and LRP6 exceeded those achieved in previous studies concerning the role of LRP5 and LRP6 in anthrax toxin internalization. A) RT-PCR analysis of LRP5 and LRP6 levels in HeLa cells transfected either with cognate pools of siRNAs or with siRNAs directed against luciferase (negative control). These experiments were each performed with triplicate samples and the mean average results are shown along with the standard deviation of the data indicated by error bars. B) Immunoblot analysis of LRP5 and LRP6 protein levels in cells transfected with the pools of siRNAs described in panel A. To control for equivalent cellular protein levels imunoblot analysis was also conducted on tubulin. C) The relative levels of LRP5 and LRP6 proteins in each sample shown in panel B were quantitated relative to the levels of tubulin in each sample using the fluorescence-scanning method described in materials and methods . LRP6 AND LRP5 ARE NOT IMPORTANT FOR INTOXICATION OF HELA CELLS To test the importance of LRP6 and/or LRP5 for anthrax toxin entry, HeLa cells transfected with different siRNAs were tested for their susceptibility to intoxication in the presence of varied amounts of PA 83 and a fixed